Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate
-
Published:2024-06
Issue:
Volume:
Page:
-
ISSN:0360-3016
-
Container-title:International Journal of Radiation Oncology*Biology*Physics
-
language:en
-
Short-container-title:International Journal of Radiation Oncology*Biology*Physics
Author:
Singh Maneesh,
Maitre Priyamvada,
Krishnan Anuradha,
Adsul Ketaki,
Mini Sreekumar Sarath,
Chauhan Harshdeep,
Bishnu Pranav Narayan,
Phurailatpam Reena,
Singh Pallavi,
Kamble Divya,
Bakshi Ganesh,
Pal Mahendra,
Arora Amandeep,
Misra Ankit,
Prakash Gagan,
Murthy VedangORCID
Reference33 articles.
1. Clinically localized prostate cancer: AUA/ASTRO guideline. Part III: principles of radiation and future directions;Eastham;J Urol,2022
2. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol,2016
3. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial;Widmark;Lancet,2019
4. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial;Tree;Lancet Oncol,2022
5. Late toxicity for prostate cancer patients treated with hypofractionated helical tomotherapy;Cekani;Rep Pract Oncol Radiother,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献